OCX logo

OncoCyte (OCX) Cash From Investing

Annual CFI

-$932.00 K
+$3.41 M+78.53%

December 31, 2023

Summary

Performance

1-Year Change

+78.53%

3-Year Change

+92.07%

5-Year Change

-2906.45%

15-Year Change

-210.56%

OCX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.22%
OCX annual cash flow from investing activities is higher than 44.22% of companies in Healthcare sector

High & Low

All-time High

$1.32 M
OCX annual cash flow from investing activities is currently -170.61% below its historical high of $1.32 million

3-Year Low

-$13.96 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
OCX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 11, 2025
OCX next annual earnings announcement is scheduled for Apr 11, 2025

OtherOCXcash flowmetrics:

Annual CFF

$12.19 M
OCX annual cash flow from financing activities is $12.19 million

Annual CFO

-$23.32 M
OCX annual cash flow from operations is -$23.32 million

Annual FCF

-$23.61 M
OCX annual free cash flow is -$23.61 million

Annual CAPEX

$281.00 K
OCX annual capital expenditures is $281.00 thousand

Quarterly CFI

-$87.00 K
+$104.00 K+54.45%

September 30, 2024

Summary

Performance

3-Month Change

+54.45%

1-Year Change

-140.65%

3-Year Change

+92.22%

5-Year Change

+92.22%

OCX Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.87%
OCX quarterly cash flow from investing activities is higher than 43.87% of companies in Healthcare sector

High & Low

All-time High

$486.00 K
OCX quarterly cash flow from investing activities is currently -117.90% below its historical high of $486.00 thousand

3-Year Low

-$1.56 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OCX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 11, 2025
OCX next earnings announcement is scheduled for Apr 11, 2025

OtherOCXcash flowmetrics:

Quarterly CFF

-$255.00 K
OCX quarterly cash flow from financing activities is -$255.00 thousand

Quarterly CFO

-$5.55 M
OCX quarterly cash flow from operations is -$5.55 million

Quarterly FCF

-$5.64 M
OCX quarterly free cash flow is -$5.64 million

Quarterly CAPEX

$87.00 K
OCX quarterly capital expenditures is $87.00 thousand

TTM CFI

-$199.00 K
-$301.00 K-295.10%

September 30, 2024

Summary

Performance

3-Month Change

-295.1%

1-Year Change

+89.17%

3-Year Change

+94.27%

5-Year Change

+94.27%

OCX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

53.22%
OCX TTM cash flow from investing activities is higher than 53.22% of companies in Healthcare sector

High & Low

All-time High

$843.00 K
OCX TTM cash flow from investing activities is currently -123.61% below its historical high of $843.00 thousand

3-Year Low

-$13.96 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OCX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 11, 2025
OCX next earnings announcement is scheduled for Apr 11, 2025

OtherOCXcash flowmetrics:

TTM CFF

$9.56 M
OCX TTM cash flow from financing activities is $9.56 million

TTM CFO

-$19.78 M
OCX TTM cash flow from operations is -$19.78 million

TTM FCF

-$20.35 M
OCX TTM free cash flow is -$20.35 million

TTM CAPEX

$566.00 K
OCX TTM capital expenditures is $566.00 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

OCX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+78.5%-140.7%+89.2%
3 y3 years+92.1%+92.2%+94.3%
5 y5 years-2906.4%+92.2%+94.3%

OCX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+93.3%-140.7%+94.4%-147.8%+98.6%
5 y5-yearat high+93.3%-140.7%+99.0%-147.8%+99.1%
alltimeall time-170.6%+93.3%-117.9%+99.2%-123.6%+99.1%

OncoCyte Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$87.00 K(-54.5%)
-$199.00 K(-295.1%)
Jun 2024
-
-$191.00 K(+695.8%)
$102.00 K(-75.5%)
Mar 2024
-
-$24.00 K(-123.3%)
$416.00 K(-144.6%)
Dec 2023
-$932.00 K(-78.5%)
$103.00 K(-51.9%)
-$932.00 K(-49.3%)
Sep 2023
-
$214.00 K(+74.0%)
-$1.84 M(-36.9%)
Jun 2023
-
$123.00 K(-109.0%)
-$2.91 M(-29.9%)
Mar 2023
-
-$1.37 M(+71.1%)
-$4.15 M(-4.4%)
Dec 2022
-$4.34 M(-68.9%)
-$802.00 K(-6.6%)
-$4.34 M(+10.2%)
Sep 2022
-
-$859.00 K(-23.2%)
-$3.94 M(+13.4%)
Jun 2022
-
-$1.12 M(-28.4%)
-$3.47 M(-52.1%)
Mar 2022
-
-$1.56 M(+289.3%)
-$7.25 M(-48.1%)
Dec 2021
-$13.96 M(+18.8%)
-$401.00 K(+1.8%)
-$13.96 M(-0.7%)
Sep 2021
-
-$394.00 K(-91.9%)
-$14.06 M(-0.9%)
Jun 2021
-
-$4.89 M(-40.8%)
-$14.19 M(+2.6%)
Mar 2021
-
-$8.27 M(+1561.0%)
-$13.83 M(+17.7%)
Dec 2020
-$11.75 M(-5.4%)
-$498.00 K(-5.3%)
-$11.75 M(-5.8%)
Sep 2020
-
-$526.00 K(-88.4%)
-$12.47 M(-46.2%)
Jun 2020
-
-$4.53 M(-26.8%)
-$23.18 M(+24.2%)
Mar 2020
-
-$6.19 M(+409.1%)
-$18.65 M(+50.2%)
Dec 2019
-$12.41 M
-$1.22 M(-89.2%)
-$12.41 M(+10.9%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$11.23 M(>+9900.0%)
-$11.20 M(<-9900.0%)
Jun 2019
-
-$11.00 K(-123.4%)
$27.00 K(+28.6%)
Mar 2019
-
$47.00 K(>+9900.0%)
$21.00 K(-167.7%)
Dec 2018
-$31.00 K(-103.7%)
$0.00(-100.0%)
-$31.00 K(-16.2%)
Sep 2018
-
-$9000.00(-47.1%)
-$37.00 K(-36.2%)
Jun 2018
-
-$17.00 K(+240.0%)
-$58.00 K(-116.5%)
Mar 2018
-
-$5000.00(-16.7%)
$352.00 K(-58.2%)
Dec 2017
$843.00 K(-565.7%)
-$6000.00(-80.0%)
$843.00 K(+13.8%)
Sep 2017
-
-$30.00 K(-107.6%)
$741.00 K(-2.8%)
Jun 2017
-
$393.00 K(-19.1%)
$762.00 K(+138.1%)
Mar 2017
-
$486.00 K(-550.0%)
$320.00 K(-276.8%)
Dec 2016
-$181.00 K(-157.5%)
-$108.00 K(+1100.0%)
-$181.00 K(-186.6%)
Sep 2016
-
-$9000.00(-81.6%)
$209.00 K(-20.2%)
Jun 2016
-
-$49.00 K(+226.7%)
$262.00 K(-15.8%)
Mar 2016
-
-$15.00 K(-105.3%)
$311.00 K(-1.3%)
Dec 2015
$315.00 K(-76.1%)
$282.00 K(+540.9%)
$315.00 K(+854.5%)
Sep 2015
-
$44.00 K(>+9900.0%)
$33.00 K(-400.0%)
Jun 2015
-
$0.00(-100.0%)
-$11.00 K(0.0%)
Mar 2015
-
-$11.00 K
-$11.00 K
Dec 2014
$1.32 M(-5380.0%)
-
-
Dec 2013
-$25.00 K
-
-

FAQ

  • What is OncoCyte annual cash flow from investing activities?
  • What is the all time high annual CFI for OncoCyte?
  • What is OncoCyte annual CFI year-on-year change?
  • What is OncoCyte quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for OncoCyte?
  • What is OncoCyte quarterly CFI year-on-year change?
  • What is OncoCyte TTM cash flow from investing activities?
  • What is the all time high TTM CFI for OncoCyte?
  • What is OncoCyte TTM CFI year-on-year change?

What is OncoCyte annual cash flow from investing activities?

The current annual CFI of OCX is -$932.00 K

What is the all time high annual CFI for OncoCyte?

OncoCyte all-time high annual cash flow from investing activities is $1.32 M

What is OncoCyte annual CFI year-on-year change?

Over the past year, OCX annual cash flow from investing activities has changed by +$3.41 M (+78.53%)

What is OncoCyte quarterly cash flow from investing activities?

The current quarterly CFI of OCX is -$87.00 K

What is the all time high quarterly CFI for OncoCyte?

OncoCyte all-time high quarterly cash flow from investing activities is $486.00 K

What is OncoCyte quarterly CFI year-on-year change?

Over the past year, OCX quarterly cash flow from investing activities has changed by -$301.00 K (-140.65%)

What is OncoCyte TTM cash flow from investing activities?

The current TTM CFI of OCX is -$199.00 K

What is the all time high TTM CFI for OncoCyte?

OncoCyte all-time high TTM cash flow from investing activities is $843.00 K

What is OncoCyte TTM CFI year-on-year change?

Over the past year, OCX TTM cash flow from investing activities has changed by +$1.64 M (+89.17%)